'Norplant' Ghosts Haunt Titan/Braeburn Buprenorphine Implant
This article was originally published in Scrip
Executive Summary
Even with new data, US regulators appeared to question whether Titan Pharmaceuticals Inc. and its partner privately held Braeburn Pharmaceuticals Inc. can safely market Probuphine, a matchstick-size subdermal implant intended to deliver buprenorphine to treat opioid dependence.